Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.78%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B0.00%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA-0.02%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%HD+0.05%3988.HK-1.13%BAC+0.05%1816.HK+3.45%GE-0.03%0857.HK-0.49%ORCL-0.01%UNH+0.01%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.02%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.12%ETHUSD+71.01%USDTUSD+0.12%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+2.04%XMRUSDT-0.10%DOGEUSD+69.80%LINKUSD+2.76%XLMUSD-0.62%BCHUSDT-0.85%LTCUSD+68.40%UNIUSD-0.56%TONUSD+79.92%SUIUSD+1.62%HBARUSDT+0.17%TAOUSDT+2.20%AAVEUSD+1.40%ONDOUSDT+1.02%DOTUSDT+1.46%ICPUSDT+3.05%WLDUSDT+3.76%ARBUSDT+2.22%ATOMUSDT-0.24%INJUSDT+3.96%STXUSDT+3.39%PYTHUSDT+4.67%TIAUSDT+3.05%FETUSDT-0.08%SEIUSDT+0.59%JUPUSDT+3.25%GRTUSDT+0.60%OPUSDT+1.55%IOTAUSDT+2.06%POLUSDT+0.45%WIFUSDT+1.51%AXSUSDT+0.01%EOSUSDT+0.37%IMXUSDT+0.09%FARTCOINUSDT+1.07%GALAUSDT+2.69%DYDXUSDT+0.05%ORDIUSDT+2.48%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL+1.78%NVDA+3.63%AMZN+1.69%SPCX+1.42%TSM+2.78%AVGO+2.47%META+1.21%TSLA+1.46%LLY+0.01%WMT+0.08%JPM-0.04%BRK-B0.00%V+0.01%SKHY0.00%AMD+3.30%MU+2.48%XOM0.00%JNJ+0.15%MA-0.02%ABBV+0.08%ASMLa-9.33%COST+0.19%1398.HK+0.25%KO+0.03%CVX+0.03%0700.HK-1.26%PG+0.09%CSCO+0.07%0939.HK0.00%HD+0.05%3988.HK-1.13%BAC+0.05%1816.HK+3.45%GE-0.03%0857.HK-0.49%ORCL-0.01%UNH+0.01%1288.HK-0.45%PM+0.02%0005.HK-3.08%NVS-0.01%HSBA.L-3.62%INTC+3.30%AZN-0.01%MS+0.02%RTX+0.02%ORp-0.36%TMO+0.14%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.12%ETHUSD+71.01%USDTUSD+0.12%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+2.04%XMRUSDT-0.10%DOGEUSD+69.80%LINKUSD+2.76%XLMUSD-0.62%BCHUSDT-0.85%LTCUSD+68.40%UNIUSD-0.56%TONUSD+79.92%SUIUSD+1.62%HBARUSDT+0.17%TAOUSDT+2.20%AAVEUSD+1.40%ONDOUSDT+1.02%DOTUSDT+1.46%ICPUSDT+3.05%WLDUSDT+3.76%ARBUSDT+2.22%ATOMUSDT-0.24%INJUSDT+3.96%STXUSDT+3.39%PYTHUSDT+4.67%TIAUSDT+3.05%FETUSDT-0.08%SEIUSDT+0.59%JUPUSDT+3.25%GRTUSDT+0.60%OPUSDT+1.55%IOTAUSDT+2.06%POLUSDT+0.45%WIFUSDT+1.51%AXSUSDT+0.01%EOSUSDT+0.37%IMXUSDT+0.09%FARTCOINUSDT+1.07%GALAUSDT+2.69%DYDXUSDT+0.05%ORDIUSDT+2.48%NOTUSDT+1.19%RONINUSDT+1.91%
AR

Ardelyx, Inc. (ARDX)

NASDAQ • Healthcare

$2.99
-$0.06 (-2.3%)
Market open

Last close at November 20, 2026 at 21:00 UTC

Open$3.01
Previous Close$2.99
Day Range$2.95 - $3.08
Avg. Volume (3M)4.9M
Market Cap$751.6M
52 Week Range
$2.8$8.4
Next EarningsIn 88 daysFeb 18, 2027

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$127.6M100%
Gross Profitminus cost of goods$123.1M96%
Operating Incomeminus R&D and overhead$4M3%

In plain terms: out of every $100 in revenue, Ardelyx, Inc. currently loses $1.

Fundamentals & Financials

Revenue (TTM)
$468.2M
Net Income (TTM)
-$55.4M
EPS (TTM)
-$0.22
ROA (TTM)
-9.44%
Current Ratio
3.45

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-15.4%Q2 2026-$0.15
-7.0%Q3 2026-$0.07
+82.1%Q4 2026$0
Next

Feb 18

in 88 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +82.1%

Ardelyx’s revenue rose ~16% year over year to about $127.7 million in the third fiscal quarter of 2026, based on preliminary results reported November 3, 2026, coming in line with consensus as revenue of $127.7 million versus a $128.0 million estimate (-0.3%). Sales remain centered on tenapanor across its gastrointestinal and cardiorenal focus, with revenue up from about $110.3 million a year ago. Profitability stayed high, with gross profit of roughly $123.1 million translating to a gross margin of ~96%. Cash generation was modest in the quarter, with operating cash flow of about $2.2 million. For the next period, consensus calls for EPS of $0.03 on revenue of $141.8 million.

View full earnings history

About Ardelyx, Inc.

Ardelyx, Inc. is a NASDAQ-listed biotechnology company focused on gastrointestinal and cardiorenal conditions, with tenapanor as its marketed product and pipeline anchor. The company generated $407.3 million of revenue in FY2025. Ardelyx changed its name from Nteryx, Inc. and operates from Waltham, Massachusetts.

Name
Ardelyx, Inc.
CEO
Michael G. Raab
Industry
Healthcare
Year Founded
2007
Employees
489

Today's Snapshot

AI-generated

ARDX closed 2.3% lower on heavier trading than usual.

Trading Volume

Above 10d avg 4.3M

6M

vs S&P 500 Today

Outperforming Market

+1.20%

Updated: November 20, 2026 at 21:07 UTC

Technical Indicators

0 Buy3 Neutral5 Sell
ARDX is rated sell largely because price sits beneath virtually all moving averages and volume patterns show persistent outflow. The trend indicator is weak, but the more telling signs are the price relationship to the short-, medium- and long-term averages — all above the current level — and a notably negative on-balance volume reading that signals distribution. Momentum and oscillators are mostly neutral to mildly negative, and ATR shows modest volatility, so the move lacks strong trending confirmation but remains biased lower while the pivot is slightly above the market. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$3.07 - $4.76
    Sell
  • RSI (14)43.07
    Neutral
  • Stochastic %K (14, 3, 3)42.08
    Neutral
  • MACD Level (12, 26)-0.05
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.